GPS Wealth Strategies Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73
Closed -$18K 1173
2022
Q3
$18K Sell
73
-8
-10% -$2.16K ﹤0.01% 645
2022
Q2
$20K Hold
81
0.01% 626
2022
Q1
$27K Hold
81
0.01% 543
2021
Q4
$29K Sell
81
-16
-16% -$5.41K 0.01% 515
2021
Q3
$32K Hold
97
0.01% 485
2021
Q2
$30K Hold
97
0.01% 518
2021
Q1
$30K Buy
+97
New +$31K 0.01% 476

Other funds holding ABMD

GPS Wealth Strategies Group's ABMD Position: Q4 2022 in Review

GPS Wealth Strategies Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 73 shares — an estimated $18K sold.

GPS Wealth Strategies Group first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $32K in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • GPS Wealth Strategies Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 73 Abiomed Inc shares in Q4 2022, an estimated $18K.
  • GPS Wealth Strategies Group first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • GPS Wealth Strategies Group's Abiomed Inc position peaked at $32K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2022, filed 27 Jan 2023.